Hussein Sultan

7PUBLICATIONS
66CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
CD4+ T cells play distinct roles during the priming versus effector phases of immune checkpoint therapy-dependent tumor elimination by CD8+ T cells.

|Apr 17, 2026
Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity.

|Apr 15, 2026
mRNA vaccines engage unconventional pathways in CD8+ T cell priming.

|Nov 25, 2024
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition.

Aaron E Fan, Hussein Sultan, Takumi Kumai

|Jul 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.

Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward

|May 20, 2024
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry.

Wei Meng, Yoshiko Takeuchi, Jeffrey P Ward

Pageof 2

Frequent Collaborators

6 joint publications

Robert D Schreiber

3 joint publications

Maxim N Artyomov

3 joint publications

Yoshiko Takeuchi

2 joint publications

Cora D Arthur